Defunct Company
Total Trials
13
As Lead Sponsor
9
As Collaborator
4
Total Enrollment
737
NCT00289003
The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2003
Completion: Jul 31, 2006
NCT00288392
Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
Start: Jun 30, 2005
Completion: Sep 30, 2006
NCT00283426
Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns
Phase: Phase 1
Start: Jan 31, 2006
Completion: Mar 31, 2007
NCT01016002
Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Role: Collaborator
Completion: Not specified
NCT00533364
Effect of SBG in Patients With Breast Cancer
Phase: Phase 1/2
Start: Jan 31, 2007
Completion: Jan 31, 2010
NCT00632008
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
Phase: Phase 3
Start: Mar 31, 2007
Completion: Oct 31, 2009
NCT00533728
Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma
Start: Sep 30, 2007
Completion: Mar 31, 2009
NCT00790322
Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy
Start: Oct 31, 2008
Completion: Feb 28, 2010
NCT00804414
Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers
Completion: Sep 30, 2009
NCT01415986
Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers
Start: Nov 30, 2010
Completion: Mar 31, 2012
NCT01718223
Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer
Phase: N/A
Start: Dec 31, 2013
Completion: Aug 31, 2014
NCT02631512
Evaluation of Woulgan in Diabetic Foot Ulcer
Phase: Phase 4
Start: Oct 31, 2015
Completion: Apr 30, 2019
NCT03757728
Randomized Trial :Hemorrhoidal Pedicle Ligation vs Laser vs Open Hemorrhoidectomy
Start: Apr 30, 2016
Completion: Nov 30, 2018